-
Subject Areas on Research
-
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
-
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.
-
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
-
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
-
Celecoxib (celebrex) increases canine lower esophageal sphincter pressure.
-
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
-
Celecoxib does not delay cutaneous wound healing in haemophilia B mice.
-
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
-
Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor.
-
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
-
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.
-
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
-
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.
-
How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.
-
Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation.
-
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
-
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
-
Primary systemic therapy in HER2-amplified breast cancer: a clinical review.
-
ROC curve estimation under test-result-dependent sampling.
-
Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract.
-
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304.
-
Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer.
-
The STAMPEDE trial and celecoxib: how to adapt?
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
-
Utilization of a Preemptive, Multimodal Analgesic Regimen in Adult Ambulatory Septoplasty Patients: A Quality Improvement Project.